SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-158510
Filing Date
2024-06-10
Accepted
2024-06-10 20:30:56
Documents
1
Group Members
MARIJN E DEKKERSNOVALIS LIFESCIENCES INVESTMENTS II GP, LLCPAUL M. MEISTER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d829691dsc13da.htm SC 13D/A 83247
  Complete submission text file 0001193125-24-158510.txt   85079
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Subject) CIK: 0001850079 (see all company filings)

IRS No.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92630 | Film No.: 241034433
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1 LIBERTY LANE E SUITE 112 HAMPTON NH 03842
Business Address 1 LIBERTY LANE E SUITE 112 HAMPTON NH 03842 603-339-0084
Novalis LifeSciences Investments II, L.P. (Filed by) CIK: 0001890017 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A